Lonza Group AG (LONN.VX)

LONN.VX on Virt-X Level 1

108.20CHF
6:24am EST
Price Change (% chg)

CHF0.10 (+0.09%)
Prev Close
CHF108.10
Open
CHF108.10
Day's High
CHF109.10
Day's Low
CHF107.40
Volume
32,862
Avg. Vol
214,580
52-wk High
CHF118.60
52-wk Low
CHF79.00

LONN.VX

Chart for LONN.VX

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a... (more)

Overall

Beta: 1.39
Market Cap (Mil.): CHF5,720.67
Shares Outstanding (Mil.): 52.92
Dividend: 2.15
Yield (%): 1.99

Financials

  LONN.VX Industry Sector
P/E (TTM): 30.27 21.39 25.23
EPS (TTM): 3.57 -- --
ROI: 3.26 6.70 14.44
ROE: 8.81 8.58 16.62
Search Stocks

BRIEF-Lonza establishes manufacturing agreement with Celladon

* Lonza and Celladon corporation establish a strategic commercial manufacturing collaboration for Mydicar Further company coverage:

03 Nov 2014

UPDATE 2-Lonza shares drop after revenue forecast cut on weak water business

* Shares fall as much as 8.5 pct (Recasts with fall in shares, adds analyst comments)

31 Oct 2014

BUZZ-Lonza tumbles on revenue forecast downgrade

** Shares in Lonza fall 5 pct to 110.0 Swiss francs after the specialty chemicals and life science group lowers its full-year revenue forecast.

31 Oct 2014

BRIEF-Lonza falls 3.5 pct after lowers revenue forecast

ZURICH, Oct 31 - Lonza Group AG falls 3.5 percent after it lowers its full-year revenue forecast. Further company coverage: (Reporting by Caroline Copley)

31 Oct 2014

BRIEF-Lonza CEO says has no divestment plans at present

Oct 31 - Citigroup Inc : * Lonza CEO says company does not have any divestment projects ongoing right

31 Oct 2014

Lonza lowers revenue forecasts on weak water business

ZURICH, Oct 31 - Switzerland's Lonza revised down its forecast for full-year revenue growth on Friday as bad weather weighed on its water business.

31 Oct 2014

BRIEF-Lonza decides to keep its wood protection business

Oct 31 - Lonza Group AG : * Says has decided to retain its wood protection business

31 Oct 2014

Lonza courts biotech backers to shore up outsourcing contracts

ZURICH - Swiss drugs industry supplier Lonza Group AG is courting the financial backers of biotech firms to help secure a steady stream of projects and offset some of the volatility of outsourced production contracts, a senior executive said.

22 Aug 2014

Lonza courts biotech backers to shore up outsourcing contracts

ZURICH, Aug 22 - Swiss drugs industry supplier Lonza Group AG is courting the financial backers of biotech firms to help secure a steady stream of projects and offset some of the volatility of outsourced production contracts, a senior executive said.

22 Aug 2014

UPDATE 2-Lonza profit boosted by drug production outsourcing

* Shares up 5.8 pct (Recasts with share price, adds analyst)

24 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks